Brief: Quince Therapeutics Settles Approximately $16.4 Million Of Debt
30/03/2026 15:09
March 30 (Reuters) - Quince Therapeutics Inc QNCX.O: QUINCE THERAPEUTICS SETTLES APPROXIMATELY $16.4 MILLION OF DEBT Source text: ID:nBw9dLCyra Further company coverage: QNCX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on IRulya Therapeutics
See all newsBrief: Quince Therapeutics - Changes Name To Irulya Therapeutics
Brief: Quince Therapeutics - Appoints Brigette Roberts As CEO Effective October 8, 2026
Quince Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Quince Therapeutics Reports Second Quarter 2026 Financial Results And Corporate Update
Quince Therapeutics Q2 net loss widens on acquisition charges